Search
forResearch 10 of 1000+
- IL-36γ drives skin toxicity induced by EGFR/MEK inhibition and commensal Cutibacterium acnes
- When bugs and drugs conspire: driving acneiform skin toxicity
- Scalp Pustule as a Manifestation of Erlotinib-Induced Skin Toxicity: Report of Two Cases and Literature Review
- Skin toxicity caused by EGFR antagonists—An autoinflammatory condition triggered by deregulated IL‐1 signaling?
- Taiwanese Dermatological Association consensus for the prevention and management of epidermal growth factor receptor tyrosine kinase inhibitor-related skin toxicities
- Management of Dermatologic Toxicities
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management
- Topical Application of Aprepitant Inhibits Erlotinib-induced Facial Dermatitis/Hair Loss
- Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →